Calcium carbonate (Amorphical)/Colecalciferol/Risedronate Sodium Hydrate

碳酸钙/胆骨化醇/利塞膦酸钠

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCalcium carbonate (Amorphical)/Colecalciferol/Risedronate Sodium Hydrate

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionBone development modulatorsVitamin D receptor agonistsFarnesyl diphosphate synthase inhibitors

TargetsVitamin D receptorFarnesyl diphosphate synthase

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryEU

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeM05BB07